NR3C1 and psoriasis: The results demonstrated that econazole (antibiotic), methylprednisolone and dexamethasone (glucocorticoid receptor agonist), idalopirdine (serotonin receptor antagonist) among others were targeting the core network, implying their potential to be utilized for psoriasis treatments (Tables 3, and S5).